Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
Sales | 2,931,943 | 2,970,264 | 2,833,913 | 2,992,838 | 2,861,969 |
Cost of Goods | 760,000 | 742,000 | 745,000 | 808,000 | 763,000 |
Gross Profit | 2,172,000 | 2,228,000 | 2,089,000 | 2,186,000 | 2,099,000 |
Operating Expenses | 1,298,000 | 1,456,000 | 1,261,000 | 1,588,000 | 1,276,000 |
Operating Income | 873,943 | 772,264 | 827,913 | 596,838 | 822,969 |
Interest Expense | 0 | 0 | 247,000 | 0 | 0 |
Other Income | 57 | -264 | 87 | -330,838 | 31 |
Pre-tax Income | 874,000 | 772,000 | 581,000 | 266,000 | 823,000 |
Income Tax | 253,000 | 230,000 | 0 | 11,000 | 215,000 |
Net Income Continuous | 620,817 | 541,994 | 580,991 | 255,825 | 608,008 |
Net Income | $620,817 | $541,994 | $580,991 | $255,825 | $608,008 |
EPS Basic Total Ops | 0.31 | 0.27 | 0.29 | 0.13 | 0.30 |
EPS Basic Continuous Ops | 0.31 | 0.27 | 0.28 | 0.12 | 0.30 |
EPS Diluted Total Ops | 0.31 | 0.27 | 0.29 | 0.13 | 0.30 |
EPS Diluted Continuous Ops | 0.31 | 0.27 | 0.29 | 0.12 | 0.30 |
EBITDA(a) | $873,943 | $772,264 | $827,913 | $596,838 | $822,969 |